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The growing recognition that brain pathologies do not affect neurons only but rather are,
to a large extent, pathologies of glial cells as well as of the vasculature opens to new per-
spectives in our understanding of genetic disorders of the CNS. To validate the role of the
neuron-glial-vascular unit in the etiology of genome instability disorders, we report about
cell death and morphological aspects of neuroglia networks and the associated vascula-
ture in a mouse model ofAtaxiaTelangiectasia (A-T), a human genetic disorder that induces
severe motor impairment. We found that A-T-mutated protein deficiency was consistent
with aberrant astrocytic morphology and alterations of the vasculature, often accompanied
by reactive gliosis. Interestingly similar findings could also be reported in the case of other
genetic disorders. These observations bolster the notion that astrocyte-specific patholo-
gies, hampered vascularization and astrocyte-endothelium interactions in the CNS could
play a crucial role in the etiology of genome instability brain disorders and could underlie
neurodegeneration.
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INTRODUCTION
Over the past two decades a large body of evidence has emerged
supporting the possibility that glia cells are not playing second
fiddle to neuronal activity but rather they hold a key role in brain
functionality. Astrocytes are the most abundant type of glial cells
in the brain and are characterized by a complex morphology
with highly degree of branching. They are involved in synaptic
glutamate uptake, metabolic support of the neuronal cell bod-
ies, and processes and contracts with blood vessels (Verkhratsky
and Parpura, 2010; Barzilai, 2011). Under normal physiological
conditions, astroglial cells buffer extracellular K+concentrations
regulate neurotrophic factors release, and control extracellular
concentrations of neurotransmitters released from neighboring
synapses. In addition, astrocytes regulate water movement and dis-
tribution and are capable of neutralizing reactive oxygen species
(ROS) in the vicinity of neurons and other types of cells. Astro-
cytes play a major role in metabolic support of adjacent neuronal
cells by absorbing glucose from the nearby blood vessels, convert-
ing it to lactate, and providing it to neurons. Under patholog-
ical conditions, astrocytes experience metabolic stress and may
contribute to CNS damage. Under these conditions astrocytes
release ROS and NO, which in turn can generate highly toxic
radicals such as hydroxyl radical and peroxynitrite. Pathologi-
cal astrocytes fail to regulate water homeostasis, thereby favoring
the insurgence of edema. Under these conditions, a reversal of
neurotransmitter transporters take place and high levels of dif-
ferent substances are released together with cytotoxic levels of
Ca2+ contributing to glutamate cytotoxicity. Failure to buffer
extracellular K+ concentrations promotes further over-excitation
of neuronal cells. Under these conditions glial cells secrete proin-
flammatory factors in conjunction with ROS, further exacerbating
CNS damage.
Astrocytes are subdivided into two classes based on their mor-
phological features and location in the CNS. Fibrous astrocytes
are predominat in the gray matter, while in the white matter pro-
toplasmic astrocytes are the majority (Miller and Raff, 1984). Few
relevant features characterize human astrocytes in comparison to
rodents, the most studied animal model. First, astrocytes in higher
primates display a much larger complexity. Second, the human
protoplasmic astrocytes have about 40 main processes with far
more complex ramifications compared to mouse astrocytes. More-
over, every human protoplasmic astrocyte can enwrap about two
million synapses, while only 100,000 synapses are covered by the
processes of mouse astrocytes (Oberheim et al., 2006).
Astrocytes, apart “ruling” on their own territories, form func-
tional networks, can display various shapes and carry out numer-
ous functions. Although astrocytes express receptors and ion chan-
nels similarly to neurons, they do not produce action potentials but
display calcium events which can propagate and synchronize with
nearby cells. Furthermore, astrocytes act as pluripotent neural pre-
cursors supporting adult neurogenesis (reviewed in Verkhratsky
and Steinhauser, 2000; Volterra and Meldolesi, 2005; Haydon and
Carmignoto, 2006).
The potential importance of the astrocytic biochemical dynam-
ics at single cell and network level has motivated parallel theoretical
investigations aimed at unraveling the possible functional role
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of such astrocytic signaling. For example, intensive investigation
was devoted to develop a biophysical model of glutamate-induced
astrocytic intracellular calcium signals which could capture the
essential biochemical features of the regulatory pathway of inos-
itol 1,4,5-trisphosphate (IP3; De Pittà et al., 2009, 2011). While
previous attempts to depict the complicated intracellular calcium
dynamics did not provide a comprehensive biological description,
this latter model focuses on the interplay between calcium dynam-
ics and astrocyte functionality brought forth by the regulation of
the intracellular second messenger IP3. At network level, one of the
most interesting features of astrocytic calcium dynamics is their
capability to communicate with each other over long distances by
calcium waves. Such waves spread intercellularly through molecu-
lar gates called gap junctions, which connect directly intracellular
spaces of each of the cells in the network. Computer modeling
aimed at discovering what biophysical mechanisms could support
long-distance propagation of calcium wave signaling suggests that
IP3 diffusion through gap junctions is non-linear (Goldberg et al.,
2010). This is a rather unexpected prediction since gap junctions
are classically considered to allow linear (Fickian) diffusion. Along
with necessary experimental verification, these new ideas pro-
vide another avenue in the process of deciphering long-distance
communication between astrocytes.
ASTROCYTES IN BRAIN DYSFUNCTION
Recent evidences strengthen the doctrine that glial cells play a
crucial role in both neural functionality and brain activity. These
findings should lead us to reconsider their contribution in neu-
ropathology and injury as well (Seifert et al., 2006). This global
perspective in the normal brain might yield new insights about
how glial cells may participate in the pathogenesis of common
neurological disorders such as Alzheimer’s and Parkinson’s dis-
eases, stroke, epilepsy, and primary brain tumors (Bachoo et al.,
2004). As a result, the investigation of brain disorders becomes a
complex multi-aspect problem, where neurons and glial cells are
equally influential as they are closely reacting with each other.
Damage to, or injury in the CNS results in the formation
of a “glial scar” (Fawcett and Asher, 1999). This is consistent
with reactive gliosis which occurs in order to facilitate the con-
tainment of the injury and the initiation of repair processes. It
includes microglia recruitment, higher presence of oligodendro-
cyte precursors, mobilization of meningeal cells and a combined
morphological-functional alteration of the astrocytes. Because
astrocytes constitute nearly half of the cells in the human brain,
there is essentially no CNS disease that does not involve them.
That is, following a traumatic tissue injury, astrocytes undergo
significant morphological changes and thereby functional alter-
ations, which are usually referred to as reactive gliosis (astrogliosis)
state. In response to the CNS damage, astrocytic structural changes
are accompanied by the secretion of regulatory molecules which
astrocytes express such as VEGF, endothelins, and ephrins/Eph-
receptors (Li et al., 2007). These array of different molecules are
known to modulate neuronal development, axonal growth, and
vasculogenesis (Fagan et al., 2004; Eichmann et al., 2005). The
astrocyte reactive response was found to be substantially involved
in most brain dysfunctions. Remarkably, astrocytes are capable of
accurately adjusting their reaction to the specific insult, according
to the relevant characteristics of the pathology, the site of injury
(Ridet et al., 1997), the stage of development, and the magnitude of
the damage. They determine the type and the quantity (Eddleston
and Mucke, 1993; Ridet et al., 1997) of molecules which are nec-
essary to control the damage, to diminish its affects and to initiate
repair processes.
Although reactive astrocytosis is beneficial to isolate infections
and to assist the sealing of damaged blood-brain barrier, it can also
be harmful. While glial scarring substantially contributes to the
glial cues that inhibit axonal regeneration (Silver and Miller, 2004),
reactive astrocytes upregulate synapse-inducing gene expression
such as thrombospondins, which facilitates the recovery of CNS
insults (Liauw et al., 2008). Another downside of reactive astroglio-
sis is the possible induction of unwanted synapses that can cause
epilepsy or neuropathic pain (Boroujerdi et al., 2008). In addition,
mutant astrocytes carrying the sodium dismutase SOD1 (G93A)
allele are capable of releasing a toxic signal that can rapidly kill
wild-type motor neurons (Di Giorgio et al., 2007; Lobsiger and
Cleveland, 2007; Nagai et al., 2007).
Neurological diseases, including demyelinating diseases and
epilepsy, can result from mutations in astrocyte-specific genes.
More supporting evidence to the major involvement of astrocytes
in neuropathologies was reported in various cases. In brain stroke,
the lack of blood flow which is followed by reperfusion which has
a combined effect. On one side it upregulates antioxidants and free
radicals scavengers in the ischemic region and it increases oxida-
tive stress. The astrocytes at the ischemic as well as in the vicinity
of ischemic areas play an important role in protecting neurons
from mounting oxidative stress (Kraig et al., 1995), and shield the
area during the disturbance of blood flow. On the other side, gap
junctional communication in astrocytes was reported to propa-
gate and amplify the effects of cell injury by allowing intercellular
diffusion of death signals that kill adjacent cells (Lin, 1998). Such
a “bystander effect” could account for secondary effects at sites
distant from the brain injury.
In an attempt to understand the astrocytes unique contribu-
tion in brain pathologies, a few unexpected morphological changes
and functional roles of these cells were discovered. For instance,
it was shown that in some cases the astrocytes’ domains partially
overlap, and they are no longer carefully spaced, but distributed
in mix in each other’s territory (Lin, 2008). Furthermore, the
connexin (Cx) expression levels changes in response to different
cues of specific diseases and this could directly cause shrink-
ing of the astrocytic network. In the case of localized injuries it
was observed gradualism and flexibility of the reactive astrocytes
response, i.e., Cx expression levels vary in correlation with spa-
tial proximity to the injured place (Ochalski et al., 1995; Theriault
et al., 1997; Koulakoff et al., 2008). In brain tissues derived from
patients with Alzheimer’s disease (in situ analysis), the expression
of Cx43 was increased in reactive astrocytes surrounding amy-
loid plaques (Nagy et al., 1996). After hypoxic preconditioning,
Cx43-containing hemichannels release ATP, which is converted
to adenosine – a signaling neuromodulator which acting at CNS
synapses to restrict synaptic activity and protect neurons (Lin,
2008).
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DNA DAMAGE RESPONSE AND ATAXIA TELANGIECTASIA
An aberrant response to DNA lesions is implicated in many human
neurodegenerative disorders (reviewed in Abner and McKinnon,
2004; Barzilai et al., 2008). In healthy cells, the accumulated DNA
damage is rapidly detected, leading to the activation of an intricate
web of signaling pathways known as the DNA damage response
(DDR). On the other hand, in cells with neurodegenerative dys-
function some components of the DDR machinery are impaired
(reviewed in Barzilai et al., 2008). Under normal conditions this
response culminates in activation of cell-cycle checkpoints and
appropriate DNA repair pathways and in certain contexts, initi-
ation of cell death programs. The DDR is a hierarchical process
executed through a series of steps. The DNA lesions are detected by
sensor proteins that recognize the lesions themselves or chromatin
alterations that may result from the DNA damage. Transducers are
then brought into action to convey the damage signal to down-
stream effectors. It is this relay system from transducers to effectors
that enables a single DNA lesion to modulate numerous pathways.
The transducers might also be involved in the assembly of DNA-
repair complexes at the sites of DNA damage (reviewed in Zhou
and Elledge, 2000; Iliakis et al., 2003; Shiloh, 2003; Su, 2006).
Following double stranded breaks (DSB) induction, the Ataxia
Telangiectasia mutated (ATM) protein is activated and a portion of
nuclear ATM binds to DSB sites (Andegeko et al., 2001; Meyn et al.,
2003). Part of the activation process of ATM involves autophos-
phorylation of serine 1981 and subsequent dissociation of inactive
ATM dimers into active monomers (Bakkenist and Kastan, 2003).
The fraction of ATM that binds is also autophosphorylated (Uziel
et al., 2003), but recent data indicate that this autophosphoryla-
tion is not necessary for ATM recruitment to damage sites (Meyn
et al., 2003). Activation of the ATM kinase seems to be an initiating
event in cellular responses to irradiation. ATM may be activated by
various stresses in addition to DSBs (Kurz and Lees-Miller, 2004).
Downstream of the transducer proteins are targets that control
various cellular processes such as DNA repair, cell-cycle progres-
sion, gene transcription, protein synthesis and degradation, and
apoptosis (Banin et al., 1998; Canman et al., 1998; Bakkenist
and Kastan, 2003; Lavin, 2007; Matsuoka et al., 2007; Weterings
and Chen, 2007; Lempiainen and Halazonetis, 2009; Panier and
Durocher, 2009; Bennetzen et al., 2010; Kaidi et al., 2010; Miller
et al., 2010; Morris et al., 2010; Nakada et al., 2010; Polo et al.,
2010).
THE CHROMOSOMAL INSTABILITY SYNDROME ATAXIA
TELANGIECTASIA
The ATM protein was identified as the product of the gene that
is mutated in the human genetic disease Ataxia Telangiectasia (A-
T). A-T is characterized by progressive cerebellar degeneration,
immunodeficiency, genome instability, premature aging, gonadal
dysgenesis, extreme radiosensitivity, and high incidence of lym-
phoreticular malignancies (for review, see Lavin and Shiloh, 1997;
Biton et al., 2008). One of the most devastating symptoms of A-
T – cerebellar ataxia – develops progressively into general motor
dysfunction. One of the main causes of death of A-T patients
is aspiration due to cerebellar-related swallowing defects. Post-
mortem studies reveal a significant loss of Purkinje and granule
neurons in the cerebellum of children with A-T and therefore
once considered as a “Purkinje disease.” Clearly, the cerebellar
neurons are seriously damaged due to the loss of ATM, although
weather this is a second effect to the glial cells damage, or a parallel
independent damage, is yet to be revealed.
According to the glial doctrine, brain pathologies can be to very
great extent pathologies of glia which fail to function properly and
determine the degree of neuronal death, the outcome and the
scale of neurological deficit. If this would apply indeed to genomic
instability disorders and A-T in particular, new avenues for treat-
ments could be developed by supplementing the diseased tissue
with healthy glial cells and glial-associated supportive factors.
To test the validity of the glial doctrine we analyzed the role
astrocytic morphology in a mouse model of A-T in which the
ATM gene was knocked out. As shown in Figure 1, the complex
arborization of Atm-deficient astrocytes is reduced. In particular,
the number of processes originating from a single cell body is sig-
nificantly lower in Atm−/− astrocytes in comparison to the WT
cells, with average value respectively of 3.65± 1 (n= 12; Different
representing cells; three different cultures) and 7.5± 1.5 (n= 12;
Different representing cells; three different cultures; p< 0.001;
Figure 1). To further characterize the glial morphology in other
genomic instability disorders we studied the mouse model of
Nijmegen breakage syndrome (NBS). NBS is a genomic instabil-
ity disorder caused by hypomorphic mutations in the Nbs1 gene.
When Nbs1 is conditionally inactivated in the central nervous sys-
tem of mice (Nbs1-CNS-∆), animals suffer from severe cerebellar
atrophy, ataxia, and white matter damage. We observed that condi-
tional inactivation of the murine Nbs1 gene has a profound effect
on the integrity and the functionality of the glial cells, which sug-
gests their crucial role in the pathogenesis of NBS (Galron et al.,
2011). Conditional disruption of Nbs1 led to a significant reduc-
tion and disorganization in the CNS derived from Nbs1-CNS-D
mice. Using magnetic resonance imaging (MRI) and region of
interest analysis of the T2 maps revealed severe impairment of
the white matter in Nbs1-CNS-∆ brains. Biochemical analysis
showed low and dispersed staining for myelin basic protein and
oligodentrocytes’ progenitor cells in Nbs1-CNS-∆ brains, indicat-
ing defects in myelin formation and oligodendrocyte development
(Assaf et al., 2008).
Additionally, we focused on neurotrophic factors since they play
an important role in the maintenance of the CNS homeostasis.
Astrocytes are known to produce and secrete their own reper-
toire of neurotrophic factors, including BDNF and NT3 (Ma et al.,
2005). Recent data suggest that a dysfunction in glial cell activity
may contribute to the pathogenic process that leads to neurode-
generative Diseases (Ma et al., 2005). Interestingly, Western blot
analysis revealed a significant reduction in the levels of BDNF and
NT3 in the cerebellum of Atm−/− (Figure 2). Collectively, these
results suggest that astrocytic cell dysfunction in Atm−/− mice
play a major role in CNS abnormalities in A-T patients.
VASCULATURE
The interactions between astrocytes and endothelial cells are cru-
cial for the formation of the blood–brain barrier (BBB) and in
vascular disease pathology. The BBB is a separation of circulating
blood from the brain extracellular fluid (BECF) in the CNS. It
occurs along all capillaries and consists of tight junctions around
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FIGURE 1 | Glial cell alterations in primary cultures derived from
Atm−/− mice. M Immunocytochemical stainingof Glial Fibrillary Acidic
Protein (GFAP), a marker of astrocytes (green), and Neuronal Nuclei marker
NeuN (red). Note, that Atm−/− astrocytes display significantly less
processes in comparison to WT astrocytes. Magnification: left column ×20;
center and right column ×40.
FIGURE 2 | Reduction in neurotrophic mediatorsAtm−/− mice.
Western blot analysis displaying reduction in BDNF and NT3 (protein levels
in Atm−/− mice (n=3) and NT3 (n= 3). Error bars represent SEM
(statistical analysis was performed using two-tailed Students t test.
the capillaries that do not exist in normal circulation. Endothelial
cells restrict the diffusion of microscopic objects (e.g., bacteria)
and large or hydrophilic molecules into the cerebrospinal fluid
(CSF), while allowing the diffusion of small hydrophobic mole-
cules (O2, CO2, hormones). Cells of the barrier actively transport
metabolic products such as glucose across the barrier with specific
proteins. This barrier also includes a thick basement membrane
and astrocytic endfeet. The BBB is composed of high-density cells
restricting passage of substances from the bloodstream much more
than endothelial cells in capillaries elsewhere in the body. Astrocyte
cell projections called astrocytic feet (also known as“glia limitans”)
surround the endothelial cells of the BBB, providing biochem-
ical support to those cells. The BBB is distinct from the quite
similar blood–CSF barrier, which is a function of the choroidal
cells of the choroid plexus, and from the blood–retinal barrier,
which can be considered a part of the whole realm of such bar-
riers (Hamilton et al., 2007). The interactions between astrocytes
and endothelial cells also play an important part in brain develop-
ment and function. It was demonstrated that in mouse embryos,
the endothelin family member Edn3 (Inoue et al., 1989) acting
through the endothelin receptor EdnrA (Arai et al., 1990; Sakurai
et al., 1990), directs extension of axons of a subset of sympa-
thetic neurons from the superior cervical ganglion to a preferred
intermediate target, the external carotid artery, which serves as
the gateway to select targets, including the salivary glands (Makita
et al., 2008), deliver trophic support as well as differentiation sig-
nals to neurons and stem cells (Shen et al., 2004; Dugas et al.,
2008), and provide a niche for neural stem cells (Tavazoie et al.,
2008). Furthermore, their crucial role at forming BBB is heavily
supported in cases of brain injuries (Tavazoie et al., 2008). The
reactive astrocytes take critical part in the formation of a shield
which encapsulates the brain injury (Bush et al., 1999).
Some brain disorders may have a vascular origin (Forstl et al.,
1991; Baldwin and O’brien, 2002), and vascular diseases can be
directly linked to neuronal and synaptic dysfunction through
changes in the blood flow, increases in BBB permeability, and in
changes in nutrient supply (Zlokovic, 2008). As the brain lacks a
reserve of glucose and oxygen, it is wholly dependent on a constant
blood supply. A threat to cerebral perfusion is likely to have dra-
matic consequences on neuronal functions. Vascular diseases may
lead to activated astrocytes and microglial cells resulting in elevated
expression of inducible nitric oxide synthase (iNOS) and release of
neurotoxic ROS and nitric oxide. The inflammatory mechanisms
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may be aggravated by continuous release of chemokines such as
CCL2 and CCL3 by astrocytes (McKimmie and Graham, 2010).
Furthermore, oxidative stress and glucose starvation may lead
to the impairment of astrocyte glutamate uptake, which in turn
results in glutamate neurotoxicity. The neurologic symptoms of
Aicardi Goutieres syndrome (AGS) are most similar to those
patients with Cockayne syndrome (CS). These diseases are char-
acterized by demyelination, brain calcification, and reduced DNA
repair. AGS and CS also display vascular degeneration particu-
larly affecting microvessels (reviewed in Brooks et al., 2008). These
observations suggest that abnormal vasculature plays a role in the
etiology of neurological diseases that are associated with genomic
instability.
We recently found that Atm−/− mice have severely impaired
retinal vascularization and leaky blood vessels (Raz-Prag et al.,
2011). This finding highlights the neuro-glio-vascular interrela-
tions previously observed (Petzold et al., 2008). We characterized
the retina in young and aged Atm-deficient mice. At 2 months of
age, angiography revealed slightly impaired retinal vasculature in
Atm−/− relative to wild-type controls. Labeling for GFAP and
CD31 for endothelial cells demonstrated diminution of astrocytes
coverage of the vessels inAtm−/− retinas (Figure 3). These results
suggest that impaired vascularization in the CNS plays an impor-
tant role in the etiology of A-T and those vascular abnormalities
may underlie or aggravate neurodegeneration.
Astrocyte – endothelial cell interaction plays a major role in
the function of the vascular unit, and dysfunction in their interac-
tion may lead to microhemorrhages (Lifshitz, 2009). Furthermore,
astrocytes are known to regulate the brain’s endothelial barrier
by releasing soluble factors such as VEGF (Fruttiger, 2007). In
addition to the retinal we investigated cerebellar astrocytes by
examining the levels of GFAP in cerebellar slices. Using confocal
microscopy, we targeted the interaction of astrocytes (marked by
GFAP) with endothelial cells (marked by CD31). As shown in
Figure 4, in retinas of WT mice, the processes of the astrocytes
appear to form an even network that encases the blood vessels,
whereas in WT cerebella the astrocytes fully coat the blood and
assume fibrous appearance. On the other hand, in Atm-deficient
cerebella, the astrocytes fail to coat the blood vessels and acquired
morphology of activated astrocytes, as found in cases of gliosis,
and seem to be unable to form a continuous regular net alongside
the blood vessels. These results suggest that Atm deficiency leads
to pathological changes in astrocytes and impairs their ability to
support the blood vessels.
In our previous study (Raz-Prag et al., 2011), we found evidence
of vascular leakage inAtm−/− retinas. Using confocal microscopy,
we found that fibrinogen labeling was observed in clusters out-
side blood vessels in Atm−/− retinas whereas it colocalized with
the endothelial cell marker in the retinas of WT mice. Indeed,
increases in fibrinogen levels, as well as reduced occludin content,
have been previously associated with increased vascular perme-
ability (Antonetti et al., 1998; Tyagi et al., 2008). To further extend
FIGURE 4 | Alterations in the glial-vascular interactions in cerebellar
sections derived fromAtm−/− mice. Confocal images of cerebellar
sections from WT and Atm−/− mice, labeled for CD31 (red) and GFAP
(green).
FIGURE 3 | Glial cell alterations in retinas ofAtm−/− mice. Confocal images of flat-mount retinas from WT and Atm−/− mice, labeled for CD31 (red) and
GFAP (green). Magnification: ×4.
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FIGURE 5 | Increased fibrinogen expression in retinas ofAtm−/− mice.
Confocal images of cerebellar sections of mice at 2 months of age show
markedly increased fibrinogen immunoreactivity (red) in blood vessels
(stained with the pan-endothelial marker CD3, green) of Atm−/− mice
compared to the labeling in WT controls. Cell nuclei are stained with Sytox
Blue (blue).
FIGURE 6 | Vascular leakage in cerebella ofAtm−/− mice. Cerebellar
section derived from WT and Atm−/− mice were stained for hemosiderin to
indicate deposits resulting from microhemorrhages. The lower panel shows a
larger magnification of WT and Atm−/− cerbella. Blue deposits of
hemosiderin were evident in cerebella of Atm−/− mice (several indicated
with arrows), but scarcely in cerebella of WT mice.
this analysis we analyzed vascular integrity in cerebellar slices. Sim-
ilar to Atm-deficient retinas, Atm deficiency causes increased level
of fibrinogen (Figure 5).
To directly demonstrate whether Atm deficiency leads to
increased cerebellar blood vessels’ permeability we analyzed the
levels of hemosiderin cerebellar slices derived from WT and
Atm−/−mice. Deposits of hemosiderin are breakdown products
of hemoglobin and reflect microhemorrhages that occurred pre-
viously (Viswanathan and Chabriat, 2006). Immunohistological
analysis revealed deposits of hemosiderin in Atm−/− cerebel-
lar slices, whereas WT retinas lacked evidence of such deposits
(Figure 6).
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CONCLUDING REMARKS
Although a vast body of evidence has documented astrocyte dys-
function, and even dysregulation of astrocyte-specific functions
in various neurological diseases, it is still not possible to por-
tray a global unifying picture. This might be, at least in part,
due to the fact that the term “astrocyte” covers a heteroge-
neous group of cells, including highly polarized and differen-
tiated cells as well as stem cells, and all this makes compari-
son of individual studies difficult (Seifert et al., 2006). Indeed,
molecular, functional, and structural definition of astrocyte het-
erogeneity is a rapidly evolving field, and a better definition
of astrocyte subtypes (similarly to what has been provided for
GABAergic interneurons in (Ascoli et al., 2008), should greatly
promote our understanding of their specific roles in patho-
physiology. Here we present evidence that malfunctioning DDR
severely affects astrocyte functionality. We found that Atm defi-
ciency significantly reduced processes’ complexity of astrocytes.
We also discovered a significant reduction in the secretion of
neurotrophic factors, such as brain-derived neurotrophic factor
and neurotrophin 3. Furthermore, our data suggest an important
role for astrocyte–vascular interaction in Atm-deficient mice and
probably A-T patients. Atm deficiency leads to increased blood
vessels’ permeability evidenced by increased fibrinogen levels and
microhemorrhages.
Another important open question is whether astrocytic net-
works affect neuronal activity (reviewed in Giaume et al., 2010).
So far, this question has been rather difficult to address owing to
the lack of specific tools for studying astrocyte Cx channels.
Mathematical modeling of neuroglial interactions could help
to determine the role of single astrocytes and astrocytic networks.
While several groups have attempted to create a coherent model
of astrocyte calcium signal propagation and responses to neuronal
activity, only a few have modeled the feedback of astrocytic activity
on neurons (De Pittà et al., 2011). The use of computer simulations
trying to imitate those processes could yield significant advances
in understanding the neuroglial interactions.
Progress in the field of glio-biology during the past few
years indicates that this could lead to the development of novel
cell-centered therapeutic approaches to neurological disorders.
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